AAAAAA

   
Results: 1-10 |
Results: 10
Tyrosine kinase inhibitors. 18. 6-substituted 4-anilinoquinazolines and 4-anilinopyrido [3,4-d]pyrimidines as soluble, irreversible inhibitors of theepidermal growth factor receptor
Authors: Smaill, JB Showalter, HDH Zhou, HR Bridges, AJ McNamara, DJ Fry, DW Nelson, JM Sherwood, V Vincent, PW Roberts, BJ Elliott, WL Denny, WA
Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 18. 6-substituted 4-anilinoquinazolines and 4-anilinopyrido [3,4-d]pyrimidines as soluble, irreversible inhibitors of theepidermal growth factor receptor, J MED CHEM, 44(3), 2001, pp. 429-440
Chemical inhibitors of protein kinases
Authors: Bridges, AJ
Citation: Aj. Bridges, Chemical inhibitors of protein kinases, CHEM REV, 101(8), 2001, pp. 2541-2571
Dermatomyositis after interferon alpha treatment
Authors: Dietrich, LL Bridges, AJ Albertini, MR
Citation: Ll. Dietrich et al., Dermatomyositis after interferon alpha treatment, MED ONCOL, 17(1), 2000, pp. 64-69
Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts
Authors: Vincent, PW Bridges, AJ Dykes, DJ Fry, DW Leopold, WR Patmore, SJ Roberts, BJ Rose, S Sherwood, V Zhou, HR Elliott, WL
Citation: Pw. Vincent et al., Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts, CANC CHEMOT, 45(3), 2000, pp. 231-238
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]-pyrimidine-6-acrylamides bearing additional solubilizing functions(vol 43, pg 1380, 2000)
Authors: Smaill, JB Rewcastle, GW Bridges, AJ Zhou, HR Showalter, HDH Fry, DW Nelson, JM Sherwood, V Elliott, WL Vincent, PW DeJohn, DE Loo, JA Greis, KD Chan, OH Reyner, EL Lipka, E Denny, WA
Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]-pyrimidine-6-acrylamides bearing additional solubilizing functions(vol 43, pg 1380, 2000), J MED CHEM, 43(16), 2000, pp. 3199-3199
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in Apc(Min) mice but induces duodenal injury
Authors: Ritland, SR Gendler, SJ Burgart, LJ Fry, DW Nelson, JM Bridges, AJ Andress, L Karnes, WE
Citation: Sr. Ritland et al., Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in Apc(Min) mice but induces duodenal injury, CANCER RES, 60(17), 2000, pp. 4678-4681
The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases
Authors: Bridges, AJ
Citation: Aj. Bridges, The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases, CURR MED CH, 6(9), 1999, pp. 825-843
Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity
Authors: Wilson, RB Gluck, OS Tesser, JRP Rice, JC Meyer, A Bridges, AJ
Citation: Rb. Wilson et al., Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity, J RHEUMATOL, 26(2), 1999, pp. 402-407
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno [3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase
Authors: Showalter, HDH Bridges, AJ Zhou, HR Sercel, AD McMichael, A Fry, DW
Citation: Hdh. Showalter et al., Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno [3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase, J MED CHEM, 42(26), 1999, pp. 5464-5474
Tyrosine kinase inhibitors. 15. 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[d] pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor
Authors: Smaill, JB Palmer, BD Rewcastle, GW Denny, WA McNamara, DJ Dobrusin, EM Bridges, AJ Zhou, HR Showalter, HDH Winters, RT Leopold, WR Fry, DW Nelson, JM Slintak, V Elliot, WL Roberts, BJ Vincent, PW Patmore, SJ
Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 15. 4-(phenylamino)quinazoline and 4-(phenylamino)pyrido[d] pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor, J MED CHEM, 42(10), 1999, pp. 1803-1815
Risultati: 1-10 |